The effect of clofibrate with phototherapy in late pre-term newborns with non-hemolytic jaundice

Indian Journal of Medical Sciences

Volumn 63, Issue 5, 2009, Pages 174-179

  Sakha, Sedigheh Hossein ^a   Gharehbaghi, Manizheh ^a,b   Rahbani, Mohammad ^a  

^a UNIVERSITY OF TABRIZ   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Clofibrate; Late pre term neonate; Non hemolytic jaundice; Phototherapy

Indexed keywords

BILIRUBIN; CLOFIBRATE; PLACEBO;

ARTICLE; BILIRUBIN BLOOD LEVEL; BODY WEIGHT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELIVERY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; NEWBORN; NEWBORN JAUNDICE; PHOTOTHERAPY; PREMATURITY; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; TREATMENT DURATION; VOMITING;

BILIRUBIN; CLOFIBRATE; COMBINED MODALITY THERAPY; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERBILIRUBINEMIA, NEONATAL; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; JAUNDICE, NEONATAL; MALE; PHOTOTHERAPY;

EID: 67749110063     PISSN: 00195359     EISSN: 19983654     Source Type: Journal    
DOI: 10.4103/0019-5359.53162     Document Type: Article

References (16)

1. American Academy of Pediatrics, Provisional Committee for Quality Improvement and Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004;114:297-316.
2. th ed. Philadelphia: Lippincott Williams and Wilkins; 2005. p. 768-836.
3. Dennery PA, Seidman DS, Stevenson DK. Neonatal hyperbilirubinemia. N Eng J Med 2001;344:581-90.
4. Shortland DB, Hussey M, Chowdhury AD. Understanding neonatal jaundice: UK practice and international profile. J R Soc Health 2008;128:202-6.
5. Alkalay AL, Simmons CF. Hyperbilirubinemia guidelines in newborn infants. Pediatrics 2005;115:824-5.
6. Dennery PA. Pharmacological interventions for the treatment of neonatal jaundice semin neonatal 2002;7:111-9.
7. Bruns S, Carmona MC, Mampel T, Tinas O, Giralt M, Iglesias R, et al. Activators of peroxisome prolifelator-activated receptor-alpha induce the expression of the uncoupling protein-3 gene in skeletal muscle: A potential mechanism for the lipid intake-dependent activation of uncoupling protein-3 gene expression at birth. Diabetes 1999;48:2117-122.
8. Wang G, Shen H, Rajaraman G, Roberts MS, Gong Y, Jiang P, et al. Expression and antioxidant function of liver fatty acid binding protein in normal and bile-duct ligated rats. Europ J Phamacol 2007;560:61-8.
9. Lindenbaum A, Hernandorena X, Vial M, Benattar C, Janaud JC, Dehan M, et al. [Clofibrate for the treatment of hyperbilirubinemia in neonates born at term: A double blind controlled study (author's transl)]. Arch Fr Pediatr 1981;38:867-73.
10. Mohammadzadeh A, Farhat AS, Iranpour R. Effect of clofibrate in jaundiced term newborns. Indian J Pediatr 2005;72:123-6.
11. Badeli HR, Sahrafi R, Sajedi SA. The effect of clofibrate on neonatal hyperbilirubinemia in uncomplicated Juandice Iran J Ped 2008;18:20-4.
12. Zahed pasha Y, Ahmadpour-Kacho M, Hajiahmadi M, Naderi S. Effect of clofibrate in jaundiced full term infants: A randomized clinical trial. Arch Iran Med 2007;10:349-53.
13. Lindenbaum A, Delaporte B, Benattar C, Jananaud JC, Dehan M, Mogny JF Gen D, et al. Preventive treatment of jaundice in premature newborn infants with clofirate (Double blind controlled therapeutic trial) Arch Fr Pediatr 1985;42:759-63.
14. Mohammadzadeh A, Farhat AS, Jafarzadeh M, Mirzarahimi M, Esmaili H, Amiri R. Prophylactic effect of clofibrate in low birth weight neonates, hyperbilirubinemia. J Chinese Clinical Med 2008;3:140-4.
15. Zahedpasha Y, Ahmdpour-Kacho M, Hajiahmadi M, Naderi S, Kamali AA. Efficacy of clofibrate on severe neonatal jaundice associated with glucose 6 phosphate dehydrogenase deficiency (a randomized clinical trial). Southeast Asian J Trop Med Public Health 2008;39:557-61.
16. Wazir S, Angiti RR, Kumar P. Effect of clofibrate in jaundiced term neonates. Indian J Pediatr 2006;73:170.